PATH Stock Hits 52-Week Low as Outlook Cut Bites

NEW YORK, May 1 —

UiPath (PATH) is trading at $10.30, a fresh 52-week low for a company whose retail base is loud enough to call the selloff "irrational" in print. The screen looks like a value setup: 11.5x forward earnings, $474 million of free cash flow, 83% gross margin, and an analyst target implying 34% upside. The tape disagrees, and the past six weeks of filings explain why.

The Quarter That Broke the Tape

On March 11, UiPath filed an 8-K covering Items 2.02, 8.01, and 9.01 — the standard packaging for a quarterly results release. The earnings line itself was fine; UiPath has now beaten consensus three quarters running. The forward look was not. A TipRanks headline shortly afterward — "UiPath Stock Sinks as Outlook Cut Shocks Investors" — captured what happened next, and Quiver Quantitative's coverage of the same release flagged a different worry: investor questions about Anthropic eating into UiPath's automation territory.

An outlook cut on a stock priced like a growth name is the most expensive type of miss. Quality-software multiples are paid for visibility. Take the visibility away and the multiple compresses before the fundamentals do. That's the move PATH has been making since March 11.

The 8-K No One Has Explained

Two weeks after the print, UiPath filed another 8-K, dated March 25, this one covering Items 5.02, 7.01, and 9.01. Item 5.02 is the disclosure box for the departure or appointment of directors and principal officers; Item 7.01 is a Regulation FD bucket, often used to attach a press release. The filing exists on EDGAR. The "why" does not exist in the facts on the table.

An unexplained Item 5.02 inside a quarter where the company just cut its outlook is the kind of thing that markets price defensively until proven benign. Investors don't get to read the press release attached to a 7.01 with a generic Stock Titan headline; they get to read the table of contents on EDGAR and guess. The market has been guessing lower.

The Anthropic Question

The narrative pressure on PATH right now isn't really about a single quarter. It's about whether large language model providers — Anthropic specifically, per MSN coverage citing it as a driver of the slide to a 52-week low — collapse the moat under traditional robotic process automation. Quiver Quantitative raised the same question in the wake of Q4. Yahoo Finance ran two pieces in mid-April asking, more or less, whether PATH at a 33% YTD drawdown deserves a fresh look.

UiPath's response, at least operationally, is to show up where the AI workloads are going. A Stock Titan headline three days before this writing flagged a new integration linking Databricks data with UiPath's AI workflows for real-time action. Translated: UiPath wants to position itself as the orchestration layer that turns model output into automated action inside an enterprise stack, rather than a competitor to the models. Whether the market believes that pivot is a different question, and the chart suggests skepticism.

What the Insider Filings Actually Say

Insider activity over the last 90 days reads as net balanced — $0 in open-market purchases against $0 in open-market sales. Every disposition on file is a tax-withholding event tied to equity grants that vested April 1. COO and CFO Ashim Gupta got 306,748 shares granted and had 79,589 shares withheld at $11.10, roughly $883,000 in tax cover. CPO and CTO Raghavendra Malpani got 159,125 shares granted with about $379,775 withheld. Chief Legal Officer Brad Brubaker got 157,208 shares granted with about $613,652 withheld. Standard equity comp mechanics.

The more interesting line item is CEO and Chairman Daniel Dines, who reported three Form 4 transactions on March 16, each categorized as "Other" and each covering 9,615,297 shares. "Other" on Form 4 is the bin for non-standard movements — trust transfers, gifts, dispositions to estate planning vehicles — and these will not show up as buys or sells in conventional insider scorecards. They warrant a read of the underlying filing rather than a conclusion. What can be said: no executive is bidding for stock at the 52-week low with personal capital, and grant-driven dispositions don't break a tie either way.

Cheap, or Correctly Priced

The bull arithmetic is straightforward. A software business compounding revenue at 13.6% with 83% gross margins and $474 million of free cash flow does not normally trade at 11.5x forward earnings. The implied 34% gap to the average sell-side target reflects the discount Wall Street thinks is wrong.

The bear arithmetic is also straightforward. A company that just cut its outlook, just disclosed a board/officer change without a clean public explanation, and is being repeatedly named in headlines as the loser in an Anthropic-vs-RPA narrative is not a low-volatility compounder. It is a debate stock, and debate stocks trade on next quarter's print, not last quarter's beat. UiPath has now announced its Q1 FY2027 conference call, which is when the next data point lands.

What Changes the Thesis

Three things would shift the read from neutral to constructive: a Q1 print that holds the freshly-lowered guide rather than re-cutting it, evidence that the Databricks integration and similar partnerships are showing up in net new ARR, and a clean public account of the March 25 personnel change. Three things would push the other way: another guidance cut, a customer-cohort disclosure showing GenAI displacement, or open-market insider selling once the trading window reopens.

At 11.5x forward earnings with $474 million in free cash flow, PATH is cheap on the math. Whether it's cheap on the business is the question the next earnings call exists to answer.

Run the free UiPath, Inc. deep-dive →

Basis Report does not hold positions in securities discussed. This is not investment advice.

Frequently Asked Questions

Why is UiPath stock at a 52-week low?

PATH slid after a March 11 earnings release in which the company cut its forward outlook, with subsequent coverage citing Anthropic competition fears as an additional driver. The outlook cut and the unexplained March 25 Item 5.02 personnel filing are detailed above.

Is UiPath stock cheap right now?

On screening metrics, yes — PATH trades at 11.5x forward earnings with $474M of free cash flow and 83% gross margins, and analyst targets imply roughly 34% upside. The valuation breakdown is in the analysis above.

Are UiPath insiders buying or selling?

Insider activity over the last 90 days is net balanced, with all reported dispositions being tax-withholding events tied to April 1 equity vests. The Form 4 detail and Daniel Dines' "Other"-coded March 16 transactions are covered above.

What did UiPath's March 25 8-K disclose?

The filing covered Items 5.02, 7.01, and 9.01, indicating a departure or appointment of a director or principal officer alongside a Regulation FD disclosure. The implications are discussed in the report.

Is Anthropic a real threat to UiPath?

Multiple analyst and news outlets have flagged competitive concerns, and UiPath has responded with moves like the new Databricks integration positioning itself as an AI orchestration layer. The competitive framing is examined above.